The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics.
WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version.
The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal.
WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%.
Depleted New Zealand batting first against Pakistan in T20
CCTV gala's branch venues prove hit with tourists
Amazing International Fashions Integrated with Traditional Chinese Cultural Elements
Saudi Arabia set for Chinese tourists
EU proposes youth mobility agreement with UK to help youngsters travel, work and live in both areas
Peng Yan Leads Team in Developing USVs
Overseas Returnee Inherits, Revitalizes Traditional Craft
Providing Heartwarming Services to Children
Sluggish start for spring homebuying season as home sales fall in March with mortgage rates rising
Retired Textile Worker Teaches Party's History